Kca31 Channel | List of Frontiers open access articles

Brief Research Report

Published on 07 Jan 2022

LY294002 Inhibits Intermediate Conductance Calcium-Activated Potassium (KCa3.1) Current in Human Glioblastoma Cells

in Lipid and Fatty Acid Research

Concetta Caglioti
Federico Palazzetti
Lorenzo Monarca
Raffaele Lobello
Maria Rachele Ceccarini
Rossana Giulietta Iannitti
Roberta Russo
Francesco Ragonese
Chiara Pennetta
Antonella De Luca

Frontiers in Physiology

doi 10.3389/fphys.2021.790922

3,432 views
4 citations

Review

Published on 05 Oct 2022

Regulatory role of KCa3.1 in immune cell function and its emerging association with rheumatoid arthritis

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Yi Lin
Ying-Jie Zhao
Hai-Lin Zhang
Wen-Juan Hao
Ren-Di Zhu
Yan Wang
Wei Hu
Ren-Peng Zhou

Frontiers in Immunology

doi 10.3389/fimmu.2022.997621

8,366 views
22 citations

Original Research

Published on 03 Apr 2024

Vasoactive intestinal peptide excites GnRH neurons via KCa3.1, a potential player in the slow afterhyperpolarization current

in Cellular Neurophysiology

Stephanie Constantin
Clarisse Quignon
Katherine Pizano
David M. Shostak
Susan Wray

Frontiers in Cellular Neuroscience

doi 10.3389/fncel.2024.1354095

3,051 views
1 citation

Original Research

Published on 28 Feb 2020

A Compartmentalized Reduction in Membrane-Proximal Calmodulin Reduces the Immune Surveillance Capabilities of CD8+ T Cells in Head and Neck Cancer

in Pharmacology of Ion Channels and Channelopathies

Ameet A. Chimote
Vaibhavkumar S. Gawali
Hannah S. Newton
Trisha M. Wise-Draper
Laura Conforti

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00143

8,680 views
20 citations

Original Research

Published on 31 Jan 2017

Inhibition of Intermediate-Conductance Calcium-Activated K Channel (KCa3.1) and Fibroblast Mitogenesis by α-Linolenic Acid and Alterations of Channel Expression in the Lysosomal Storage Disorders, Fabry Disease, and Niemann Pick C

in Membrane Physiology and Membrane Biophysics

Aida Oliván-Viguera
Javier Lozano-Gerona
Laura López de Frutos
Jorge J. Cebolla
Pilar Irún
Edgar Abarca-Lachen
Ana J. García-Malinis
Ángel Luis García-Otín
Yolanda Gilaberte
Pilar Giraldo

Frontiers in Physiology

doi 10.3389/fphys.2017.00039

5,499 views
17 citations

Original Research

Published on 28 Feb 2025

Administration of the KCa channel activator SKA-31 improves endothelial function in the aorta of atherosclerosis-prone mice

in Pharmacology of Ion Channels and Channelopathies

O. Daniel Vera
Ramesh C. Mishra
Rayan Khaddaj-Mallat
Liam Hamm
Barak Almarzouq
Yong-Xiang Chen
Darrell D. Belke
Latika Singh
Heike Wulff
Andrew P. Braun

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1545050

2,666 views
1 citation

Articles

LY294002 Inhibits Intermediate Conductance Calcium-Activated Potassium (KCa3.1) Current in Human Glioblastoma Cells

Regulatory role of KCa3.1 in immune cell function and its emerging association with rheumatoid arthritis

Vasoactive intestinal peptide excites GnRH neurons via KCa3.1, a potential player in the slow afterhyperpolarization current

A Compartmentalized Reduction in Membrane-Proximal Calmodulin Reduces the Immune Surveillance Capabilities of CD8+ T Cells in Head and Neck Cancer

Inhibition of Intermediate-Conductance Calcium-Activated K Channel (KCa3.1) and Fibroblast Mitogenesis by α-Linolenic Acid and Alterations of Channel Expression in the Lysosomal Storage Disorders, Fabry Disease, and Niemann Pick C

Administration of the KCa channel activator SKA-31 improves endothelial function in the aorta of atherosclerosis-prone mice